My guess is the cap raising has left a few people unhappy and they're moving on. Volume doesn't look massive but it does point to a dearth of buyers.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025